[1]
B. S. Kim, “A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)”, J of Skin, vol. 6, no. 6, p. s104, Nov. 2022.